The Antinociceptive and Anti-inflammatory Action of the CHCl 3 Yoshiyuki MIZUSHINA, c Toshiko SATAKE, b and Shogo TOKUYAMA* fraction was subjected to repeated SiO 2 column chromatography using n-hexane-CHCl 3 solvent system. It was purified by preparative TLC using a CHCl 3 -MeOH solvent system to afford compounds. HPLC was performed with a Diol column (Inertsil Diol 5 mm, 4.6ϫ250 mm, GL Sciences, Tokyo, Japan). The detection wavelength was 254 nm. Elution was carried out with nhexane : CHCl 3 (a, 25 : 75), (b, 50 : 50) and (c, 75 : 25) at a flow rate of 1 ml/min. The injection volume was 10 ml (1.0 mg/ml, chloroform-soluble phase in CHCl 3 ). Damnacanthal contained in the chloroform-soluble phase could be separated by HPLC using three solvent systems (Fig. 1A) . The yields of damnacanthal from the dried root 0.434%. The purified damnacanthal were analysed by IR, UV, Sample Preparation and Drugs The MeOH (3 g/kg)-, CHCl 3 (3 g/kg)-, and BuOH (3 g/kg)-soluble phase and damnacanthal (10-100 mg/kg) were orally administrated to mice 30 min before each test. Samples were suspended in 1% CMC-Na. Indomethacin (50 mg/kg), a non-steroidal anti-inflammatory drug (NSAIDs), was orally administrated to mice 30 min before administration of each soluble phase and damnacanthal. Morphine (5 mg/kg), a m opioid receptor agonist, was subcutaneously administrated to mice 30 min before administration of each soluble phase and damnacanthal. Naloxone (NLX; 1 mg/kg, intraperitoneally (i.p.)), a non-selective opioid receptor antagonist, was administered 10 min before administration of each soluble phase.
Formalin Test The formalin test was carried out as described. 8) Mice were injected with 10 ml of 5% formalin [formaldehyde solution 37% (w/w) diluted in saline] into the subplantar space of the right hind paw 30 min after the treatment of the CHCl 3 -soluble phase (per os (p.o.)) and damnacanthal (p.o.). The times spent in licking, biting and shaking behaviors were measured during 0 to 5 min (early phase) and from 5 to 30 min (late phase) after formalin injection.
Histamine-Induced Paw Edema Histamine (0.5 mmol, 10 ml) was injected intraplantarly (i.pl.) into the right hind paw to induce acute inflammation.
9) The thickness of the injected hind paw was measured every 10 min or 60 min for 300 min after histamine injection (i.pl.). The intraperitoneal administration of diphenhydramine (30 mg/kg), a histamine H 1 receptor antagonist, was used as a positive control in the test. The area under the curve (AUC) value for the effect of restraining paw edema on each mouse was then calculated.
Histamine H 1 Receptor Binding Assay The histamine H 1 receptor binding affinity assay was conducted at Cerep Incorporated (Celle l'Evescault, France), according to an established method.
10) The influence of damnacanthal (10 Statistical Analyses Data are meanϮS.E.M. The statistical significance of differences between the control and CHCl 3 soluble phase-treated group and damnacanthal-treated group were analyzed using one-way ANOVA followed by Scheffe's multiple-comparison test for the acetic acid writhing test and formalin test. pϽ0.05 was considered significant.
RESULTS

Effect of the MeOH-, CHCl 3 -and BuOH-Soluble Phase of the Noni Root on the Chemical Nociceptive Stimuli in the Formalin Test
The CHCl 3 -soluble phase (3 g/kg) did not reduce pain response time in the early phase, but significantly suppressed pain-related behavior in the late phase (pϽ0.01) of the formalin test. Similarly, indomethacin (50 mg/kg) as a positive control significantly attenuated painrelated behavior in the late phase of the formalin test, but not the early phase. However, the MeOH (3 g/kg)-and BuOH (3 g/kg)-soluble phase had no effect in the formalin tests (Fig. 2) .
Effect of NLX on CHCl 3 Soluble Phase-Induced Antinociception The antinociceptive effect in the late phase of the CHCl 3 -soluble phase (3 g/kg) was not affected by pretreatment with NLX (1 mg/kg). On the other hand, morphine (5 mg/kg) significantly attenuated pain-related behavior in the early and late phase in a NLX-reversible manner (Fig. 3) .
Effect of the CHCl 3 -Soluble Phase of the Noni Root on Histamine-Induced Paw Edema The saline-injected hind A B paws used as control showed no increase of paw volume during the entire experiment; on the other hand, hind paw edema was successfully induced by intraplantar injection of histamine. Administration of the CHCl 3 -soluble phase showed significant inhibition of the edema. Diphenhydramine (30 mg/kg) significantly inhibited the paw edema (Fig. 4) .
Effect of Damnacanthal on Chemical Nociception in the Formalin Test Damnacanthal (10-100 mg/kg) did not reduce pain response time in the first phase, but significantly suppressed pain-related behavior in the second phase (pϽ0.01). Damnacanthal (30-100 mg/kg) exhibited a significant antinociceptive effect in a dose-dependent manner. Indomethacin (50 mg/kg) significantly reduced pain-related behavior in the second phase (Fig. 5) .
Effect of Damnacnthal on Histamine-Induced Paw Edema Administration of damnacanthal (100 mg/kg) and diphenhydramine (30 mg/kg) showed significant inhibition of histamine-induced paw edema (Fig. 6) .
Effects (Fig. 7) .
DISCUSSION
We examined the antinociceptive effect of the MeOH-, CHCl 3 -and BuOH-soluble phase in a model of acute inflammatory pain induced by formalin. In general, the early phase (0-10 min) of formalin-induced pain behavior is produced by direct stimulation of primary afferent nerves, whereas pain behaviors associated with the late phase (10-30 min) are related to the sensitization of dorsal horn neurons due to the initial barrage of primary afferent input during the early phase or the formalin-induced inflammatory reaction. 8) In the present study, we obtained evidence that the CHCl 3 -soluble phase exhibited a significant antinociceptive effect on chemical nociceptive stimuli. In particular, the CHCl 3 -soluble phase reduced pain-related behavior in the late phase. The antinociceptive effect of the CHCl 3 -soluble phase may therefore be (at least in part) due to attenuation of the central sensitization induced by certain inflammatory substances.
It is well known that opioidergic nervous systems regulate the various types of pain. The activation of opioid receptors has a pivotal role in the production of analgesic effects in animal and human. Some researchers have shown that the aqueous extracts of the fruit and roots of the Noni plant have an antinociceptive effect via opioid receptors. 11, 12) In the present study, these effects were not inhibited by pretreatment of NLX on the antinociceptive effect of the CHCl 3 -soluble phase. The CHCl 3 -soluble phase may therefore produce an antinociceptive effect without acting on opioid receptors. This discrepancy may be dependent upon the main ingredients of the Noni root.
The CHCl 3 -soluble phase may have an anti-inflammatory effect because administration of indomethacin attenuated pain-related behavior in the late phase of the formalin test. To examine the anti-inflammatory effect of the CHCl 3 -soluble phase, we evaluated histamine-induced paw edema in mice. Histamine is a potent mediator of acute inflammation. 13) It is produced in the early phase of acute inflammation to increase vascular permeability. The CHCl 3 -soluble phase significantly suppressed the paw edema induced by histamine. This test was inhibited by treatment with diphenhydramine, so this response seems to be partly mediated by the histamine H 1 receptor. Therefore, we suggest that the CHCl 3 -soluble phase exerts anti-inflammatory effects by mechanisms similar to those of histamine.
Histamine activates polymodal nociceptors and produces pain.
14) The role of histamine in pain is different in the central nervous system and peripheral nervous system. In the former, histamine H 1 and H 2 receptors are involved in the modulation of pain sensations. [15] [16] [17] In the peripheral nervous system, it is reported that pyrilamine (histamine H 1 receptor antagonist) and cimetidine (histamine H 2 receptor antagonist) show analgesic effects in the formalin test. 18) In addition, anti-histaminic drugs show antinociceptive effects on formalin-induced stimuli. [19] [20] [21] Thus, histamine seems to be involved in the stimulation of nociceptive fibers, and its antagonists show antinociceptive effects, considering histaminergic neurons are important for pain modulation. 22) We demonstrated that damnacanthal is the major component in the CHCl 3 -soluble phase of the Noni root. 5) Damnacanthal has been reported to inhibit: selective tyrosine kinase activity, 23) activation of nuclear factor kappa-B, 24) progression of cancer, 25, 26) and the human immunodeficiency virus (HIV). 27) However, there is no evidence that damnacanthal has an antinociceptive and anti-inflammatory effect on chemical nociceptive stimuli. Here, we found that damnacanthal possesses antinociceptive and anti-inflammatory effects. Therefore, in the present study, damnacanthal may have been one of the active components of the CHCl 3 -soluble phase of the Noni root. Interestingly, damnacanthal was weakly bound to the histamine H 1 receptor. Damnacanthal may therefore exert its antinociceptive and anti-inflammatory effects through binding to in part the histamine H 1 receptor.
In conclusion, we demonstrated that the CHCl 3 -soluble phase of the Noni root has antinociceptive and anti-inflammatory effects. In addition, damnacanthal was shown to be the main active component through in part a histamine H 1 receptor-mediated system in the production of these effects in the CHCl 3 -soluble phase. 
